Achieve Life Sciences (ACHV) Shares Outstanding (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Shares Outstanding (Entity) data on file, last reported at $53.2 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 53.5% year-over-year to $53.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.2 million (up 53.5% YoY) and the FY2025 annual result came in at $43.6 million, up 25.69% from the prior year.
• Shares Outstanding (Entity) advanced to $53.2 million in Q1 2026, from $43.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $53.2 million in Q1 2026 to a low of $9.5 million in Q1 2022.
• A 5-year average of $27.5 million and a median of $25.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) soared 117.99% — and 2025, when it gained 1.0%.
• Tracing ACHV's Shares Outstanding (Entity) over 5 years: stood at $10.6 million in 2022, then jumped by 99.81% to $21.2 million in 2023, then surged by 63.87% to $34.7 million in 2024, then advanced by 25.69% to $43.6 million in 2025, then advanced by 22.13% to $53.2 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $53.2 million (Q1 2026), $43.6 million (Q4 2025), and $52.8 million (Q3 2025), per Business Quant data.